Impaired Autophagic Flux in Skeletal Muscle of Plectin-Related Epidermolysis Bullosa Simplex With Muscular Dystrophy

Michaela M Zrelski1, Margret Eckhard1, Petra Fichtinger1

  • 1Division of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.

Abstract

Insights

Plectin deficiency impairs autophagy, leading to protein aggregation in epidermolysis bullosa simplex with muscular dystrophy (EBS-MD). This study reveals a link between plectin, autophagy, and muscle pathology, offering new therapeutic avenues.

Area of Science:

  • Muscle biology
  • Cellular biology
  • Molecular genetics

Background:

  • Plectin is crucial for muscle fiber integrity and intermediate filament stabilization.
  • Mutations in the PLEC gene cause epidermolysis bullosa simplex with muscular dystrophy (EBS-MD), characterized by desmin filament disorganization and myofibrillar changes.
  • Understanding protein homeostasis in EBS-MD is vital for this rare protein aggregation disease.

Purpose of the Study:

  • To investigate the role of protein degradation pathways, specifically autophagy, in the skeletal muscle pathology of EBS-MD.
  • To comprehensively analyze autophagic processes in plectin-deficient models and human tissues.
  • To explore potential therapeutic targets for plectin-related disorders.

Main Methods:

  • Analysis of protein degradation pathways and autophagic markers in human EBS-MD tissue, plectin knockout mice, and plectin-deficient cells using microscopy, RNA-Seq, qRT-PCR, and immunoblotting.
  • Dynamic assessment of autophagic turnover using mCherry-EGFP-LC3B reporter cells and organelle-specific dyes.
  • In vivo studies involving autophagy inhibition (chloroquine) and activation (metformin) in plectin-deficient mice.

Main Results:

  • Accumulation of degradative vacuoles and autophagic markers (LC3, SQSTM1) observed in EBS-MD patients, plectin-deficient mice, and cells.
  • Altered transcriptional regulation of autophagy-related genes and elevated levels of autophagosomal degradation targets.
  • Compromised autophagosome turnover and impaired autophagic clearance in plectin-deficient models, with metformin showing ameliorative effects.

Conclusions:

  • The protein aggregation pathology in EBS-MD is directly linked to impaired autophagic flux.
  • This study provides novel insights into plectin-related protein aggregation disorders.
  • Findings suggest autophagy modulation as a potential therapeutic strategy for EBS-MD.